Integra LifeSciences to participate in the Cantor Global Healthcare Conference
September 19 2018 - 4:01PM
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading
global medical technology company, will present at the following
healthcare conference in October:
- On Monday, October 1, 2018 at 4:05 p.m. ET, Sravan Emany, vice
president, treasurer & investor relations, will present at the
2018 Cantor Global Healthcare Conference in New York, NY.
About Integra LifeSciencesIntegra LifeSciences
is a global leader in regenerative technologies, neurosurgical and
extremity orthopedic solutions dedicated to limiting uncertainty
for clinicians, so they can focus on providing the best patient
care. Integra offers a comprehensive portfolio of high quality,
leadership brands that include AmnioExcel®, Bactiseal®, Cadence®,
Certas™, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®,
Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®,
SurgiMend®, TCC-EZ®, Titan™ and VersaTru™. For the latest news and
information about Integra and its brands, please visit
www.integralife.com.
Statements made at the upcoming conferences may
be forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties that could cause actual
results to differ from predicted results. Forward-looking factors
that may be discussed include, but are not limited to, future
financial performance, new product development, governmental
approvals, market potential and resulting sales as well as
potential therapeutic applications, and additional acquisitions.
These risks and uncertainties include market conditions and other
factors beyond the Company's control and the economic, competitive,
governmental, technological and other factors identified under the
heading "Risk Factors" included in item 1A of Integra's Annual
Report on Form 10-K for the year ended December 31, 2017 and
information contained in subsequent filings with the Securities and
Exchange Commission could affect actual results. These
forward-looking statements are made only as the date thereof, and
the Company undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
Investor Relations
Contacts:Sravan EmanyVice President, Treasurer &
Investor Relations(609)
936-2488sravan.emany@integralife.com
Michael BeaulieuDirector, Investor
Relations(609) 750-2827michael.beaulieu@integralife.com
Media Contact:Laurene
IsipSenior Director, Global Corporate Communications(609)
750-7984laurene.isip@integralife.com
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Aug 2024 to Sep 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Sep 2023 to Sep 2024